Hawai’i, Asia, Pacific Island Alliance (HAPA) NTM and Bronchiectasis International Conference

---

LIVE

Monday, March 8, 2027, 8:00 AM - Wednesday, March 10, 2027, 5:00 AM, Ala Moana Hotel, HI, Honolulu, HI


AMA PRA Category 1 Credits™ (14.50 hours), Non-Physician Attendance (14.50 hours)

Nontuberculous mycobacterial (NTM) lung disease is a growing clinical concern in the United States and globally. The complex and ill-defined interplay between the bacteria, their host, and environments make this disease very challenging to diagnose, manage, treat, and prevent. Additional features such as bronchiectasis, cystic fibrosis, advanced age, gender, ethnicity, diet, weight management and housing geography add additional complexity to an already difficult medical disease. This conference aims to alleviate some of this burden by bringing clinical and research topic experts together with NTM patients and their advocates for an engaging and up-date-date discussions. Further inspiration will be garnered from the conference location in Hawai’i, the U.S. state shouldering the highest number of disease cases, underscoring the need for more treatment options, improving access to clinical trials for all, and uncovering new ways to mitigate exposures. Monday: Growing significance of bronchiectasis and NTMPD in Hawai’i, Asia and the Pacific Islands Field experts will provide up-to-date information regarding host susceptibility to infection, environmental sources, outlook for MAC and M. abscessus infections, usefulness of bacterial genomics to understand disease, biomarkers discovery pipelines, and utility of phage therapy. Target audience: Pulmonologists, infectious disease physicians, general practice/family and internal medicine physicians, physician assistants, advanced practice nurses, registered nurses, and other healthcare professionals such as radiologists who diagnose and treat people with NTM. Tuesday: Important Intersections for NTM Field experts will discuss how NTM infections intersect with other clinical problems such as bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, and whether there are animal reservoirs for NTM. Finally, new resources will be shared and discussed including access to the Bronchiectasis and NTM Care Center Networks and needs to encourage more accessible clinical trials. Wednesday: Bronchiectasis and NTM Resources Speakers will address the importance of the patient voice in NTM research. Experts will discuss novel NTM biomarkers and the next generation in NTM research as well as highlight the importance of registries in tracking NTM infections.

1. Recognize host and environmental risk factors for acquiring NTM pulmonary disease
2. Summarize the epidemiology of NTM pulmonary disease
3. Describe methods to detect NTM
4. Identify therapies to treat NTM pulmonary disease
5. Explore the utility of registry data to compare local NTM pulmonary disease data to national data
6. Generate mechanisms to improve access for NTM pulmonary disease treatment

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to University of Texas at Tyler, [email protected].

University of Texas at Tyler reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
University of Texas at Tyler is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

The University of Texas at Tyler adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

University of Texas at Tyler Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.